Evidence map›Paper›PMID 25821929›Full record

ArticleAnalytical chemistry2015

Automated multiplexed ECL Immunoarrays for cancer biomarker proteins.

Karteek Kadimisetty, Spundana Malla, Naimish P Sardesai, Amit A Joshi, Ronaldo C Faria, Norman H Lee, James F Rusling

Open access · greenAbstract read
In one paragraph

Article in Analytical chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
10.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 120 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. 3D-Printed Immunosensor Arrays for Cancer Diagnostics.Sensors (Basel, Switzerland) · 2020
    Review
  9. Review
  10. Article
  11. Automated 4-Sample Protein Immunoassays using 3D-Printed Microfluidics.Analytical methods : advancing methods and applications · 2018
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Multiplexed Point-of-Care Testing - xPOCT.Trends in biotechnology · 2017
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Karteek Kadimisetty†Department of Chemistry, University of Connecticut, Storrs, Connecticut 06269, United States.
Spundana Malla†Department of Chemistry, University of Connecticut, Storrs, Connecticut 06269, United States.
Naimish P Sardesai†Department of Chemistry, University of Connecticut, Storrs, Connecticut 06269, United States.
Amit A Joshi†Department of Chemistry, University of Connecticut, Storrs, Connecticut 06269, United States.
Ronaldo C Faria∥Departamento de Química, Universidade Federal de São Carlos, São Carlos, SP 13565-905, Brazil.
Norman H Lee
James F Rusling†Department of Chemistry, University of Connecticut, Storrs, Connecticut 06269, United States.
University of Connecticut · USGeorge Washington University · USOllscoil na Gaillimhe – University of Galway · IEUniversidade Federal de São Carlos · BR

Funding

Protein Biomarker Arrays for Personalized Treatment of Prostate CancerR01EB016707 · NIBIB · UNIVERSITY OF CONNECTICUT STORRS · PI RUSLING, JAMES F. · 2014 to 2017
$1.4M
Protein Biosensor Arrays Based on NanomaterialsR01EB014586 · NIBIB · UNIVERSITY OF CONNECTICUT STORRS · PI RUSLING, JAMES F. · 2011 to 2014
$1.4M
NIBIB NIH HHS EB014586NIBIB NIH HHS EB016707NIBIB NIH HHS R01 EB014586NIBIB NIH HHS R01 EB016707
6 · The paper itself

Abstract

Point-of-care diagnostics based on multiplexed protein measurements face challenges of simple, automated, low-cost, and high-throughput operation with high sensitivity. Herein, we describe an automated, microprocessor-controlled microfluidic immunoarray for simultaneous multiplexed detection of small protein panels in complex samples. A microfluidic sample/reagent delivery cassette was coupled to a 30-microwell detection array to achieve sensitive detection of four prostate cancer biomarker proteins in serum. The proteins are prostate specific antigen (PSA), prostate specific membrane antigen (PSMA), platelet factor-4 (PF-4), and interlukin-6 (IL-6). The six channel system is driven by integrated micropumps controlled by an inexpensive programmable microprocessor. The reagent delivery cassette and detection array feature channels made by precision-cut 0.8 mm silicone gaskets. Single-wall carbon nanotube forests were grown in printed microwells on a pyrolytic graphite detection chip and decorated with capture antibodies. The detection chip is housed in a machined microfluidic chamber with a steel metal shim counter electrode and Ag/AgCl reference electrode for electrochemiluminescent (ECL) measurements. The preloaded sample/reagent cassette automatically delivers samples, wash buffers, and ECL RuBPY-silica-antibody detection nanoparticles sequentially. An onboard microcontroller controls micropumps and reagent flow to the detection chamber according to a preset program. Detection employs tripropylamine, a sacrificial reductant, while applying 0.95 V vs Ag/AgCl. Resulting ECL light was measured by a CCD camera. Ultralow detection limits of 10-100 fg mL(-1) were achieved in simultaneous detection of the four protein in 36 min assays. Results for the four proteins in prostate cancer patient serum gave excellent correlation with those from single-protein ELISA.

Indexed as

Electrochemical TechniquesLuminescent MeasurementsAntigens, SurfaceAutomationBiomarkers, TumorEnzyme-Linked Immunosorbent AssayGlutamate Carboxypeptidase IIHumansImmunoassayInterleukin-6KallikreinsPlatelet Factor 4Prostate-Specific AntigenAntigens, SurfaceBiomarkers, TumorFOLH1 protein, humanGlutamate Carboxypeptidase IIInterleukin-6KallikreinsKLK3 protein, humanPlatelet Factor 4Prostate-Specific Antigen

Identifiers

PMID25821929
PMCPMC4437514
OpenAlexW2040294415

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.